Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yoshiaki, Ochi"'
Autor:
Hisashi Nishiwaki, Kosuke Nishi, Tuti Wukirsari, Taro Kishida, Takuya Sugahara, Satoshi Yamauchi, Koichi Akiyama, Yoshiaki Ochi
Publikováno v:
Bioorganicmedicinal chemistry letters. 27(17)
The new lignano-9,9'-lactones (α,β-dibenzyl-γ-butyrolactone lignans), which showed the higher cytotoxicity than arctigenin, were synthesized. The well-known cytotoxic arctigenin showed activity against HL-60 cells (EC50=12μM), however, it was ina
Autor:
Yoshiharu Uruno, Atsushi Kitamura, Takeshi Enomoto, Akihiko Kiyoshi, Yoshiaki Ochi, Takaaki Sumiyoshi, Yasuko Konishi, Tomokazu Nakako, Atsushi Suwa, Harumi Matsuda, Kentaro Takai, Mutsuko Sakai, Yasuaki Uematsu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:2909-2912
We designed and synthesized novel N-sulfonyl-7-azaindoline derivatives as selective M4 muscarinic acetylcholine receptor agonists. Modification of the N-carbethoxy piperidine moiety of compound 2, an M4 muscarinic acetylcholine receptor (mAChR)-prefe
Autor:
Makoto Oka, Tomoko Kinoshita, Kiyoshi Furukawa, Keiko Nakamichi, Hitoshi Kohayakawa, Atsuko Kita, Yoshiaki Ochi, Kurumiya Satoshi
Publikováno v:
British Journal of Pharmacology. 142:1059-1072
We investigated the ability of N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide (AC-5216), a novel mitochondrial benzodiazepine receptor (MBR) ligand, to produce anti-anxiety and antidepressant-like effects in various a
Publikováno v:
Optics Express. 25:1769
application/pdf
Article
Optics Express. 2017, 25 (3), p.1769-1777
Article
Optics Express. 2017, 25 (3), p.1769-1777
Autor:
Yasuji Furutani, Yuki Hatayama, Hitoshi Kohayakawa, Tomoko Kiyoshi, Naoyuki Yoshida, Takashi Hashimoto, Yoshiaki Ochi
Publikováno v:
Alzheimer's & Dementia. 7
Autor:
Takeshi, Goromaru, Naofumi, Morita, Yuki, Hase, Yoshiaki, Ochi, Yoshitake, Shinohara, Kojiro, Takahashi, Seiji, Eto
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(4)
The use of injectable generic antineoplastic agents has been increasing. Few studies have compared the quality and adverse reactions of generic and branded antineoplastic agents; and therefore, generic agents have not gained wide acceptance. Paclitax
Autor:
Atsuko, Kita, Hitoshi, Kohayakawa, Tomoko, Kinoshita, Yoshiaki, Ochi, Keiko, Nakamichi, Satoshi, Kurumiya, Kiyoshi, Furukawa, Makoto, Oka
Publikováno v:
British journal of pharmacology. 142(7)
We investigated the ability of N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide (AC-5216), a novel mitochondrial benzodiazepine receptor (MBR) ligand, to produce anti-anxiety and antidepressant-like effects in various a
Autor:
Takashi Miyoshi, Mitsuru Funato, Yoon Seok Kim, Akio Kaneta, Yoshiaki Ochi, Shinichi Nagahama, Yoichi Kawakami
Publikováno v:
Applied Physics Express. 6:122704
The optical gain properties of InGaN-based green (512 nm) laser diodes fabricated on (0001) GaN substrates are investigated. Fitting simulations to the experimental gain spectra provides a Gaussian inhomogeneous broadening of 95 meV, an optical confi
Publikováno v:
Pharmacology, biochemistry, and behavior. 38(2)
The present study was undertaken to investigate the role of cholinergic mechanisms in the behavioral effects of RU-24969, a compound with serotonin1B (5-HT1B) receptor agonist properties. RU-24969 caused an increase in locomotion (2−5 mg/kg IP) and
Publikováno v:
Japanese Journal of Pharmacology. 79:233